Logo image of NLII-P.CA

NL2 CAPITAL INC (NLII-P.CA) Stock Fundamental Analysis

TSX-V:NLII-P - TSX Venture Exchange - CA6291701010 - Common Stock - Currency: CAD

0.06  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NLII-P. NLII-P was compared to 0 industry peers in the Unkown industry. No worries on liquidiy or solvency for NLII-P as it has an excellent financial health rating, but there are worries on the profitability. NLII-P has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NLII-P has reported negative net income.
NLII-P.CA Yearly Net Income VS EBIT VS OCF VS FCFNLII-P.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 -50K -100K -150K

1.2 Ratios

Industry RankSector Rank
ROA -9.99%
ROE -10.14%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NLII-P.CA Yearly ROA, ROE, ROICNLII-P.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 -5 -10 -15

1.3 Margins

NLII-P does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NLII-P.CA Yearly Profit, Operating, Gross MarginsNLII-P.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023

More info and screens

7

2. Health

2.1 Basic Checks

NLII-P has about the same amout of shares outstanding than it did 1 year ago.
There is no outstanding debt for NLII-P. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NLII-P.CA Yearly Shares OutstandingNLII-P.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 5M 10M 15M
NLII-P.CA Yearly Total Debt VS Total AssetsNLII-P.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 200K 400K 600K 800K

2.2 Solvency

An Altman-Z score of 46.26 indicates that NLII-P is not in any danger for bankruptcy at the moment.
NLII-P has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 46.26
ROIC/WACCN/A
WACCN/A
NLII-P.CA Yearly LT Debt VS Equity VS FCFNLII-P.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 200K 400K 600K 800K

2.3 Liquidity

NLII-P has a Current Ratio of 68.04. This indicates that NLII-P is financially healthy and has no problem in meeting its short term obligations.
NLII-P has a Quick Ratio of 68.04. This indicates that NLII-P is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 68.04
Quick Ratio 68.04
NLII-P.CA Yearly Current Assets VS Current LiabilitesNLII-P.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 200K 400K 600K 800K

More info and screens

0

3. Growth

3.1 Past

NLII-P shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -193.33%.
EPS 1Y (TTM)-193.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NLII-P.CA Yearly Revenue VS EstimatesNLII-P.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023
NLII-P.CA Yearly EPS VS EstimatesNLII-P.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NLII-P. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NLII-P.CA Price Earnings VS Forward Price EarningsNLII-P.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NLII-P.CA Per share dataNLII-P.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NLII-P!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NL2 CAPITAL INC

TSX-V:NLII-P (3/4/2025, 7:00:00 PM)

0.06

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners32.46%
Ins Owner ChangeN/A
Market Cap0
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.14
P/tB 1.14
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.99%
ROE -10.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 68.04
Quick Ratio 68.04
Altman-Z 46.26
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-193.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-362.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y40.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.51%
OCF growth 3YN/A
OCF growth 5YN/A